About 30 results found for searched term "HI-6" (0.024 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1863 | RAF265 | Raf |
| CHIR-265 | ||
| RAF265 is a novel, orally bioavailable dual inhibitor of RAF kinase and VEGFR2. | ||
| M2114 | GSK126 | EZH2 |
| EZH2 inhibitor; GSK2816126A | ||
| GSK126 is a potent, highly selective, S-adenosyl-methionine-competitive, small-molecule inhibitor of EZH2 methyltransferase activity. | ||
| M2659 | E-64 | Autophagy |
| Proteinase inhibitor E 64 | ||
| E-64 is an irreversible and selective cysteine protease inhibitor with IC50 of 9 nM for papain. | ||
| M2785 | JNK Inhibitor IX (SC202671) | JNK |
| TCS JNK 5a; SC-202671 | ||
| JNK inhibitor IX is a selective and potent JNK inhibitor with pIC50 of 6.5 and 6.7 for JNK2 and JNK3, respectively. | ||
| M3258 | Thioguanine | DNA/RNA Synthesis |
| 6-Thioguanine; 6-TG; 2-Amino-6-mercaptopurine; 2-Amino-6-purinethiol | ||
| Thioguanine is a purine antimetabolite widely used in the treatment of acute lymphoblastic leukemia, autoimmune disorders (e.g., Crohn's disease, rheumatoid arthritis) and organ transplant recipients. | ||
| M4786 | Aristolochic acid A | NF-κB |
| Aristolochic acid I; TR 1736 | ||
| Aristolochic acid A (Aristolochic acid I; TR 1736) is the principal component of the plant extract Aristolochic Acids, found in Aristolochia and Asarum herbs. Aristolochic acid A significantly decreased activator protein 1 (AP-1) and NF-κB activity. Aristolochic acid A reduces the expression of bladder cancer-associated BLCAP gene in human cells. | ||
| M6278 | Epothilone D | Microtubule |
| 12,13-Desoxyepothilone B; Desoxyepothilone B; KOS 862 | ||
| Epothilone D is a potent microtubule stabilizer. | ||
| M6804 | IBMX | PDE |
| IMX; Isobutylmethylxanthine; Methylisobutylxanthine; NSC165960; SC2964; 3-isobutyl-1-methylxanthine | ||
| IBMX is a pDE inhibitor (non-selective) with IC50 values of 6.5±1.2, 26.3±3.9 and 31.7±5.3 μM for PDE3, 4 and 5 respectively. | ||
| M8206 | PDI inhibitor 16F16 | Others |
| 16F16 is a protein disulfide isomerase (PDI) inhibitor, first identified in a screen for compounds that prevent apoptosis induced by mutant huntingtin protein. | ||
| M8262 | HI-6 | Others |
| HI-6 is an efficient oxime cholinesterase reactivator that is used as an antidote for organophosphates (Ops) exposure. | ||
| M9364 | Recombinant human IL-6 (CHO-expressed) | Cytokines and Growth Factors |
| Interleukin-6; rhIL-6 | ||
| Recombinant Human IL-6 is an interleukin that in humans is encoded by the IL-6 gene and acts as both a pro-inflammatory and anti-inflammatory cytokine. | ||
| M9642 | EGFR inhibitor 324674 | EGFR/HER2 |
| EGFR-IN-12 | ||
| EGFR inhibitor 324674 is a cell permeable, potent and selective EGFR inhibitor with IC50 of 21 nM. | ||
| M11041 | WEHI-9625 | VDAC |
| WEHI-9625 is a first-in-class tricyclic sulfone, first-in-class inhibitor of apoptosis with an EC50 of 69 nM. WEHI-9625 binds to VDAC2 and promotes its ability to inhibit apoptosis driven by mouse BAK. WEHI-9625 is completely inactive against both human BAK and the closely related apoptosis effector BAX. | ||
| M11197 | Recombinant Mouse IL-13 Protein (CHO, C-His) | Cytokines and Growth Factors |
| rMuIL-13, His; P600 | ||
| Recombinant Mouse IL-13 Protein is an immunoregulatory cytokine belonging to the IL-4/IL-13 family, a multifunctional cytokine whose main role is to reduce the inflammatory response. | ||
| M13761 | 5(6)-FITC | Fluorescent Dye |
| Fluorescein 5(6)-isothiocyanate; Fluorescein isothiocyanate 5- and 6- isomers | ||
| 5(6)-FITC (Fluorescein 5(6)-isothiocyanate) is an amine-reactive derivative of fluorescein dye that has wide-ranging applications as a label for antibodies and other probes, for use in fluorescence microscopy, flow cytometry and immunofluorescence-based assays such as Western blotting and ELISA. | ||
| M14255 | IK1 inhibitor PA-6 | Potassium Channel |
| PA-6 | ||
| IK1 inhibitor PA-6 (PA-6), a pentamidine analogue, is a selective and potent IK1 (KIR2.x ion-channel-carried inward rectifier current) inhibitor, with IC50 values of 12-15 nM for human and mouse KIR2.x currents. | ||
| M14905 | PKA Inhibitor Fragment (6-22) amide TFA | PKA |
| PKI-(6-22)-amide TFA | ||
| PKA Inhibitor Fragment (6-22) amide TFA is an inhibitor of cAMP-dependent protein kinase A (PKA), with a Ki of 2.8 nM. PKA Inhibitor Fragment (6-22) amide TFA can significantly reverse low-level morphine antinociceptive tolerance in mice. | ||
| M15990 | 5-Hydroxy-4-methoxycanthin-6-one | Alkaloids |
| 5-Hydroxy-4-methoxycanthin-6-one | ||
| M16018 | 5-Methoxycanthin-6-one | Alkaloids |
| 5-Methoxycanthin-6-one | ||
| M16019 | 1-Hydroxycanthin-6-one | Alkaloids |
| 1-Hydroxycanthin-6-one | ||
| M16105 | Canthin-6-one | Alkaloids |
| Canthin-6-one | ||
| M18102 | Aldehydoisoophiopogonanone A, 6- | Others |
| Aldehydoisoophiopogonanone A, 6- | ||
| M18219 | 4,5-dimethoxycanthin-6-one | Others |
| 4,5-dimethoxycanthin-6-one | ||
| M18308 | 11-Hydroxycanthin-6-one | Others |
| 11-Hydroxycanthin-6-one | ||
| M20510 | Chicago Sky Blue 6B | Others |
| A potent inhibitor of L-glutamate uptake via glutamate transporter (EAAT) | ||
| M20596 | K-Ras(G12C) inhibitor 6 | ROCK |
| K-Ras(G12C) inhibitor 6 is an allosteric, and selective inhibitor of oncogenic K-Ras(G12C). | ||
| M20680 | IRAK inhibitor 6 | IRAK |
| IRAK inhibitor 6 is a selective Interleukin-1 receptor-associated kinase 4(IRAK4) inhibitor with IC50 of 0.16 μM. | ||
| M20707 | RK 24466 | Src-bcr-Abl |
| KIN 001-51, Lck inhibitor C 8863, C8863 | ||
| RK-24466 (KIN 001-51) is a potent and selective inhibitor of Lck that inhibits two constructs of the human lck kinase, lck (64-509) and lckcd with IC50 of < 0.001 μM and 0.002 μM, respectively. | ||
| M21326 | Recombinant Schistosoma Japonicum GST (E. coli) | Cytokines and Growth Factors |
| Glutathione S-transferase class-mu 26 kDa isozyme; GST 26 | ||
| Glutathione S-Transferase (GST), an antioxidant enzyme, is involved in the primary cellular defense mechanism against reactive oxygen species. Glutathione S-transferases (GSTs), previously known as ligandins, comprise a family of eukaryotic and prokaryotic phase II metabolic isozymes best known for their ability to catalyze the conjugation of the reduced form of glutathione (GSH) to xenobiotic substrates for the purpose of detoxification. | ||
| M22513 | Mcl-1 inhibitor 6 | Bcl-2 |
| Mcl-1 inhibitor 6 is an orally active, selective myeloid cell leukemia 1 (Mcl-1) protein inhibitor with a Kd of 0.23 nM and a Ki of 0.02 μM. Mcl-1 inhibitor 6 possesses superior selectivity over other Bcl-2 family members (Bcl-2, Bcl2A1, Bcl-xL, and Bcl-w, Kd>10 μM). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
